Algeria will continue to use the drug hydroxychloroquine, known as the anti-malaria drug, to treat the coronavirus disease, a member of its scientific committee said, even after the World
Health Organisation suspended
clinical trials of the drug."We've treated thousands of cases with this medicine, very successfully so far," said Mohamed Bekkat, a member of the scientific committee on the North African country's COVID-19 outbreak. "We haven't noted any undesirable reactions," he told AFP agency.Public figures including US President Donald Trump have backed the drug as treatment for the virus, prompting governments to buy the product in bulk, despite several studies showing it to be ineffective or even counterproductive in treating COVID-19. The study found that administering the medicine, which is normally used to treat arthritis, or, separately the related anti-malarial chloroquine, actually increased COVID-19 patients' risk of dying. Both
drugs can produce potentially serious side effects, particularly heart arrhythmia.But Bekkat, who is also head of the Order of Algerian Doctors, said the country had not registered any deaths caused by hydroxychloroquine. Algeria decided in late March to treat COVID-19 patients with a combination of hydroxychloroquine and azithromycin, an antibiotic.
High Impact List of Articles
-
Road Traffic Crashes (RTCs) and its Determinants: Public Health Issue
Samina Yasmeen* Short Communication: International Journal of Collaborative Research on Internal Medicine & Public Health
-
Can We Ease the Financial Burden of Colonoscopy?
Using Real-Time Endoscopic Assessment of Polyp
Histology to Predict Surveillance Intervals
Sujievvan Chandran
Short Article: International Journal of Collaborative Research on Internal Medicine & Public Health
-
Association between Lactobacillus species and bacterial
vaginosis-related bacteria, and bacterial vaginosis scores in
small population of pregnant Latvian women
Natalija Berza , Jana Zodzika , Juta Kroica , Aigars Reinis , Ingus Skadins , Linda
Piekuse , Polina Zalizko , Olita Melngaile , Rita Pundure , Irina Lukojanova , Olga
Vasina : International Journal of Collaborative Research on Internal Medicine & Public Health
-
Single Nucleotide Polymorphism of SSU rRNA Gene among
Plasmodium Knowlesi Isolates of Sabah
Fread Anderios, Daw Khin Saw Naing, Zaw Lin, Nor Amalina Emran : International Journal of Collaborative Research on Internal Medicine & Public Health
-
Evaluation of hemoglobinopathy screening results of a six year period in Turkey
Se : International Journal of Collaborative Research on Internal Medicine & Public Health
Relevant Topics in Medical Sciences